Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China
- 7 February 2013
- journal article
- research article
- Published by Springer Nature in Journal of NeuroVirology
- Vol. 19 (2) , 144-149
Abstract
In the current era of highly active antiretroviral therapy (HAART), the incidence of HIV dementia has declined, but the prevalence of HIV-associated neurocognitive disorder (HAND) remains high. HIV-induced systemic and localized inflammation is considered to be one of the mechanisms of HAND. Changes in cytokine levels in the cerebrospinal fluid (CSF) during HIV infection might help to identify HAND. To investigate whether the cytokine profile of the CSF during HIV infection could be used as a biomarker of HAND, we compared cytokine levels in the CSF of HIV-infected cases with and without neurocognitive impairment. Cytokine concentrations in the CSF were measured by quantification bioassays (Luminex xMAP). HIV-infected cases with neurocognitive impairment demonstrated higher levels of interleukin (IL)-8, monocyte chemotactic protein (MCP)-1, induced protein (IP)-10, and granulocyte colony-stimulating factor (G-CSF) in the CSF than those without neurocognitive impairment (G-CSF (p = 0.0003), IL-8 (p = 0.0046), IP-10 (p < 0.0001), and MCP-1 (p < 0.0001)). There was no significant impact of HAART on cytokine levels in the CSF, except for IP-10, which was higher in HAART-treated patients with impaired cognition (p = 0.0182). Findings from this preliminary study suggest that elevated levels of the cytokines IL-8, MCP-1, G-CSF, and IP-10 in the CSF are associated with neurocognitive impairment in HIV infection, and these cytokines likely represent a biomarker profile for HAND.Keywords
This publication has 25 references indexed in Scilit:
- Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individualsJournal of NeuroVirology, 2011
- HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapyNeurology, 2010
- Biomarkers of immune dysfunction in HIVCurrent Opinion in HIV and AIDS, 2010
- Plasma cytokine levels during acute HIV-1 infection predict HIV disease progressionAIDS, 2010
- HIV-1 gp120-mediated increases in IL-8 production in astrocytes are mediated through the NF-κB pathway and can be silenced by gp120-specific siRNAJournal of Neuroinflammation, 2010
- CSF biomarkers of Alzheimer disease in HIV-associated neurologic diseaseNeurology, 2009
- HIV-1 gp120 induces cytokine expression, leukocyte adhesion, and transmigration across the blood–brain barrier: modulatory effects of STAT1 signalingMicrovascular Research, 2009
- Relationship between Levels of Inflammatory Cytokines in the Genital Tract and CD4+Cell Counts in Women with Acute HIV‐1 InfectionThe Journal of Infectious Diseases, 2008
- Updated research nosology for HIV-associated neurocognitive disordersNeurology, 2007
- Associative and predictive biomarkers of dementia in HIV-1–infected patientsNeurology, 2007